Munc13-4 protein was specifically decreased in all pre-symptomatic newborn samples from patients with FHL type 3, which had been used for screening for metabolic disorders and stored for months to years, in the same way as detected in post-symptomatic samples (Fig. 4A). Here, UNC13D is linked to Other metabolic disease.